248 related articles for article (PubMed ID: 18359244)
21. [Follicular non-Hodgkin lymphomas and minimal residual disease].
Bruno S
Medicina (B Aires); 2000; 60 Suppl 2():77-82. PubMed ID: 11188937
[TBL] [Abstract][Full Text] [Related]
22. Histological and immunophenotypic changes in 59 cases of B-cell non-Hodgkin's lymphoma after rituximab therapy.
Maeshima AM; Taniguchi H; Nomoto J; Maruyama D; Kim SW; Watanabe T; Kobayashi Y; Tobinai K; Matsuno Y
Cancer Sci; 2009 Jan; 100(1):54-61. PubMed ID: 19038008
[TBL] [Abstract][Full Text] [Related]
23. Impact of rituximab and/or high-dose therapy with autotransplant at time of relapse in patients with follicular lymphoma: a GELA study.
Sebban C; Brice P; Delarue R; Haioun C; Souleau B; Mounier N; Brousse N; Feugier P; Tilly H; Solal-Céligny P; Coiffier B
J Clin Oncol; 2008 Jul; 26(21):3614-20. PubMed ID: 18559872
[TBL] [Abstract][Full Text] [Related]
24. Follicular lymphoma of the duodenum: a clinicopathologic analysis of 26 cases.
Sentani K; Maeshima AM; Nomoto J; Maruyama D; Kim SW; Watanabe T; Kobayashi Y; Tobinai K; Matsuno Y
Jpn J Clin Oncol; 2008 Aug; 38(8):547-52. PubMed ID: 18687756
[TBL] [Abstract][Full Text] [Related]
25. [Non-Hodgkin lymphoma in the elderly].
Dupuis J; Haioun C
Bull Cancer; 2008 May; 95 FMC Onco():F79-83. PubMed ID: 18511372
[TBL] [Abstract][Full Text] [Related]
26. High numbers of tumor-infiltrating programmed cell death 1-positive regulatory lymphocytes are associated with improved overall survival in follicular lymphoma.
Carreras J; Lopez-Guillermo A; Roncador G; Villamor N; Colomo L; Martinez A; Hamoudi R; Howat WJ; Montserrat E; Campo E
J Clin Oncol; 2009 Mar; 27(9):1470-6. PubMed ID: 19224853
[TBL] [Abstract][Full Text] [Related]
27. Report of a workshop on malignant lymphoma: a review of molecular and clinical risk profiling.
Gleissner B; Küppers R; Siebert R; Glass B; Trümper L; Hiddemann W; Dreyling M
Br J Haematol; 2008 Jun; 142(2):166-78. PubMed ID: 18492111
[TBL] [Abstract][Full Text] [Related]
28. [Recent therapeutic progress in non-Hodgkin lymphoma: focusing on diffuse large B-cell lymphoma and follicular lymphoma].
Ogura M
Rinsho Ketsueki; 2008 Oct; 49(10):1434-50. PubMed ID: 18833928
[No Abstract] [Full Text] [Related]
29. Presence of a high-grade component in gastric mucosa-associated lymphoid tissue (MALT) lymphoma is not associated with an adverse prognosis.
Ang MK; Hee SW; Quek R; Yap SP; Loong S; Tan L; Tao M; Lim ST
Ann Hematol; 2009 May; 88(5):417-24. PubMed ID: 18777110
[TBL] [Abstract][Full Text] [Related]
30. Current controversies in follicular lymphoma.
Aurora V; Winter JN
Blood Rev; 2006 Jul; 20(4):179-200. PubMed ID: 16410034
[TBL] [Abstract][Full Text] [Related]
31. Follicular large cell lymphoma localized to the testis in children.
Pakzad K; MacLennan GT; Elder JS; Flom LS; Trujillo YP; Sutherland SE; Meyerson HJ
J Urol; 2002 Jul; 168(1):225-8. PubMed ID: 12050548
[TBL] [Abstract][Full Text] [Related]
32. Nodal follicular helper T-cell lymphoma may present with different patterns. A case report.
Qubaja M; Audouin J; Moulin JC; Molina TJ; Le Tourneau A; Gaulard P; Straub P; Audhuy B; Diebold J
Hum Pathol; 2009 Feb; 40(2):264-9. PubMed ID: 18760445
[TBL] [Abstract][Full Text] [Related]
33. Rituximab improves the efficacy of high-dose chemotherapy with autograft for high-risk follicular and diffuse large B-cell lymphoma: a multicenter Gruppo Italiano Terapie Innnovative nei linfomi survey.
Tarella C; Zanni M; Magni M; Benedetti F; Patti C; Barbui T; Pileri A; Boccadoro M; Ciceri F; Gallamini A; Cortelazzo S; Majolino I; Mirto S; Corradini P; Passera R; Pizzolo G; Gianni AM; Rambaldi A
J Clin Oncol; 2008 Jul; 26(19):3166-75. PubMed ID: 18490650
[TBL] [Abstract][Full Text] [Related]
34. Transformation of indolent B-cell lymphomas.
Montoto S; Fitzgibbon J
J Clin Oncol; 2011 May; 29(14):1827-34. PubMed ID: 21483014
[TBL] [Abstract][Full Text] [Related]
35. [Is lymphoma curable with antibody therapy?].
Leppä S; Nyman H; Karjalainen-Lindsberg ML
Duodecim; 2009; 125(3):267-73. PubMed ID: 19341039
[TBL] [Abstract][Full Text] [Related]
36. R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: the influence of prior exposure to rituximab on outcome. A GEL/TAMO study.
Martín A; Conde E; Arnan M; Canales MA; Deben G; Sancho JM; Andreu R; Salar A; García-Sanchez P; Vázquez L; Nistal S; Requena MJ; Donato EM; González JA; León A; Ruiz C; Grande C; González-Barca E; Caballero MD;
Haematologica; 2008 Dec; 93(12):1829-36. PubMed ID: 18945747
[TBL] [Abstract][Full Text] [Related]
37. Personalized immunotherapy for the treatment of non-Hodgkin lymphoma: a promising approach.
Vose J
Clin Adv Hematol Oncol; 2005 Dec; 3(12):923-32. PubMed ID: 16555434
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of p53 and matrix metalloproteinase-9 expression in follicular lymphoma.
Pennanen H; Kuittinen O; Soini Y; Turpeenniemi-Hujanen T
Eur J Haematol; 2008 Oct; 81(4):289-97. PubMed ID: 18616513
[TBL] [Abstract][Full Text] [Related]
39. Rituximab and chemotherapy in diffuse large B-cell lymphoma.
Sonet A; Bosly A
Expert Rev Anticancer Ther; 2009 Jun; 9(6):719-26. PubMed ID: 19496708
[TBL] [Abstract][Full Text] [Related]
40. Follicular lymphoma: the case for timely intervention.
McLaughlin P
Expert Rev Hematol; 2009 Jun; 2(3):277-84. PubMed ID: 21082969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
